Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 4354Neoplasms 3053Prostatic Neoplasms 1904Colorectal Neoplasms 1738Lung Neoplasms 1554Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 951Multiple Myeloma 950Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 784Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 740Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 661Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 539Recurrence 538Hodgkin Disease 531Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

Peptides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Healthy Adults × Clear all
NCT03643068 2018-11-06

Phase 1A Study of the Safety of KSP/QRH Dimer

University of Michigan

Phase 1 Completed
26 enrolled

Healthy Adults

NCT03161418 2017-12-05

Study of the Safety of KSP Heptapeptide (KSP-910638G)

University of Michigan

Phase 1 Completed
26 enrolled

Healthy Adults

Data powered by HemOnc (CC BY 4.0) Colophon âš¡